DISAPPEARANCE OF HEPATITIS-C VIRUS-RNA IN PLASMA DURING INTERFERON-ALPHA-2B TREATMENT IN HEMOPHILIA PATIENTS

被引:31
作者
BRESTERS, D
MAUSERBUNSCHOTEN, EP
CUYPERS, HTM
LELIE, PN
HAN, JH
JANSEN, PLM
HOUGHTON, M
REESINK, HW
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,1105 AZ AMSTERDAM,NETHERLANDS
[2] VAN CREVELD CLIN,BILTHOVEN,NETHERLANDS
[3] CHIRON CORP,EMERYVILLE,CA
关键词
HEMOPHILIA; HEPATITIS-C VIRUS; INTERFERON-ALPHA-2B; POLYMERASE CHAIN REACTION;
D O I
10.3109/00365529208999943
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
To establish the effect of interferon alpha-2B (IFN-alpha) treatment on hepatitis C virus (HCV) viremia, rather than monitor the alanine aminotransferase (ALAT) values we measured HCV-RNA by cDNA-polymerase chain reaction (cDNA-PCR) in plasma before and during IFN-alpha treatment. Eight hemophilia patients with chronic hepatitis C were treated with IFN-alpha for 24 weeks: 5 MU daily for 2 weeks, 2.5 MU daily for 4 weeks, and 1.5 MU three times a week for 18 weeks. HCV-RNA, as measured by cDNA-PCR, was present in all patients before treatment. After 24 weeks of treatment HCV-RNA was no longer detectable in three of eight (37.5%) patients, whereas only one of eight (12.5%) patients showed complete ALAT normalization. In three of eight patients a transient response to IFN-alpha was seen, with renewed HCV-RNA detection after dose reduction. HCV-RNA measurement by cDNA-PCR appeared to be more sensitive in detecting relapse than ALAT measurement.
引用
收藏
页码:166 / 168
页数:3
相关论文
共 8 条
  • [1] BRETTLER DB, 1990, BLOOD, V76, P254
  • [2] TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALFA - A MULTICENTER RANDOMIZED, CONTROLLED TRIAL
    DAVIS, GL
    BALART, LA
    SCHIFF, ER
    LINDSAY, K
    BODENHEIMER, HC
    PERRILLO, RP
    CAREY, W
    JACOBSON, IM
    PAYNE, J
    DIENSTAG, JL
    VANTHIEL, DH
    TAMBURRO, C
    LEFKOWITCH, J
    ALBRECHT, J
    MESCHIEVITZ, C
    ORTEGO, TJ
    GIBAS, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) : 1501 - 1506
  • [3] DIENSTAG JL, 1983, GASTROENTEROLOGY, V85, P439
  • [4] CHARACTERIZATION OF THE TERMINAL REGIONS OF HEPATITIS-C VIRAL-RNA - IDENTIFICATION OF CONSERVED SEQUENCES IN THE 5' UNTRANSLATED REGION AND POLY(A) TAILS AT THE 3' END
    HAN, JH
    SHYAMALA, V
    RICHMAN, KH
    BRAUER, MJ
    IRVINE, B
    URDEA, MS
    TEKAMPOLSON, P
    KUO, G
    CHOO, QL
    HOUGHTON, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (05) : 1711 - 1715
  • [5] HEPATITIS-C ANTIBODY AND CHRONIC LIVER-DISEASE IN HEMOPHILIA
    MAKRIS, M
    PRESTON, FE
    TRIGER, DR
    UNDERWOOD, JCE
    CHOO, QL
    KUO, G
    HOUGHTON, M
    [J]. LANCET, 1990, 335 (8698) : 1117 - 1119
  • [6] RECOMBINANT HUMAN ALPHA-INTERFERON IN PATIENTS WITH CHRONIC NON-A, NON-B HEPATITIS - A MULTICENTER RANDOMIZED CONTROLLED TRIAL FROM FRANCE
    MARCELLIN, P
    BOYER, N
    GIOSTRA, E
    DEGOTT, C
    COUROUCE, AM
    DEGOS, F
    COPPERE, H
    CALES, P
    COUZIGOU, P
    BENHAMOU, JP
    [J]. HEPATOLOGY, 1991, 13 (03) : 393 - 397
  • [7] A RANDOMIZED CONTROLLED OPEN STUDY OF INTERFERON-ALPHA-2B TREATMENT OF CHRONIC NON-A, NON-B POSTTRANSFUSION HEPATITIS - NO CORRELATION OF OUTCOME TO PRESENCE OF HEPATITIS-C VIRUS-ANTIBODIES
    SCHVARCZ, R
    WEILAND, O
    WEJSTAL, R
    NORKRANS, G
    FRYDEN, A
    FOBERG, U
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1989, 21 (06) : 617 - 625
  • [8] CONFIRMATION OF HEPATITIS-C VIRUS-INFECTION BY NEW 4-ANTIGEN RECOMBINANT IMMUNOBLOT ASSAY
    VANDERPOEL, CL
    CUYPERS, HTM
    REESINK, HW
    WEINER, AJ
    QUAN, S
    DINELLO, R
    VANBOVEN, JJP
    WINKEL, I
    MULDERFOLKERTS, D
    EXELOEHLERS, PJ
    SCHAASBERG, W
    LEENTVAARKUYPERS, A
    POLITO, A
    HOUGHTON, M
    LELIE, PN
    [J]. LANCET, 1991, 337 (8737) : 317 - 319